Moreover, inhibition of CXCL12 could also partially counteract the ability of MIR181A1HG in CRC cell-derived EVs to recruit MDSCs and remodel the ECM in the liver (Fig. 6g, h). This evidence concerns the gene CXCL12 and colorectal carcinoma.